Brief: Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer
04/06/2026 16:10
BRIEF-Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer June 4 (Reuters) - Breckenridge Pharmaceutical:
BRECKENRIDGE ANNOUNCES LAUNCH OF TOFACITINIB TABLETS, GENERIC EQUIVALENT OF XELJANZ® BY PFIZER
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TOWA PHARMACEUTICAL
See all newsTable: Towa Pharmaceutical -Q1 group results
Notice Of Acquisition Of Shares Of Tanabe Pharma Factory And Transfer Of Manufacturing And Marketing Approvals
Brief: Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer
Table: Towa Pharmaceutical -2025/26 parent results
Table: Towa Pharmaceutical -2025/26 group results